March 31, 2021
Doctor patient skin exam

Now Enrolling: EA6194 for Operable Melanoma

This phase II study, led by Dr. Ahmad Tarhini, is testing neoadjuvant treatment with pembrolizumab alone versus pembrolizumab and an investigational drug called CMP-001
May 29, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, May 2020

What we know about COVID-19; remembering Valerie Guild; spotlight on Indiana University's Melvin and Bren Simon Comprehensive Cancer Center
May 29, 2020

Remembering Valerie Guild, a Tireless Advocate for Patients with Melanoma

April 15, 2020
Patient skin exam

Now Enrolling: EA6183 Evaluating Encorafenib and Binimetinib in Metastatic Melanoma

A single-arm phase II trial evaluating the effectiveness of treatment before surgery with encorafenib and binimetinib
April 15, 2020

Remembering Uma Rao, MD